Skip to content
City PM
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
Monday 03 November 2014 8:35 am  |  Updated:  Friday 07 June 2019 3:30 pm

Could Ebola come to the UK? Woman patient tests negative at south London hospital

By: Catherine Neilan

Add as a preferred source on Google

A woman who was being tested for Ebola in a London hospital after returning from West Africa feeling unwell is free from the disease, the hospital has confirmed. 
 
The patient was admitted to St George's Healthcare NHS Trust in Tooting, south London, yesterday, triggering a series of protocols that have been put in place to protect staff and other patients from the contagious disease.
 
She was admitted to the hospital's clinical infections unit and underwent “a series of tests, as a precaution”. Although the spokesperson did not disclose the nature of the disease, they said she had tested negative for Ebola.
 
The unnamed patient will remain at St George's for the time being. 
 
A PHE spokesman said in a statement: “It is important to remember that as yet, there has not been a case of Ebola diagnosed in the UK and the infection can only be transmitted through contact with the body fluids, such as blood, vomit or faeces, of an infected person. 
 
“We have advised all frontline medical practitioners and NHS call handlers to be alert to signs and symptoms of Ebola in those returning from affected areas, and following such advice we would expect to see an increase in testing.” 
 
This is not the first time a suspected case has reached the UK, although so far all have turned out to be false alarms. 
 
In Bristol's Southmead hospital last month Adam Griffiths, who had been travelling in Africa, arrived in the accident and emergency unit where he was met with doctors wearing protective suits, before being put in isolation, but tests also proved negative. 
 
William Pooley was the first Brit to contract Ebola while he was working in West Africa, and was treated at the Royal Free hospital in London. He has since returned to Sierra Leona to continue treating people affected by the virus. 
 
Wondering where Ebola has spread to so far? We track the disease (including whether it is now considered to be contained) here.
 
Ebola is spread through bodily fluid such as blood and semen, and contagion begins from when symptoms emerge – usually two to 21 days after infection. Corpses remain contagious after death. 

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

Related Topics

  • Ebola

Trending Articles

  • Top Burnham adviser calls for capital gains and inheritance tax hikes

  • A meeting with the breakfast king of Mayfair

  • As it happened: Stocks jump on defence and metals boost; Oil on track to shed a fifth on US-Iran peace hopes

  • Clarkson’s Farm and why businesses must stop blaming the weather

  • BT tops FTSE 100 after finding new home for international business with Verizon joint venture

More from City PM

  • IMU Biosciences announces oversubscribed financing round, bringing its Series A to over $53M as it accelerates its work to decode the immune system with unprecedented resolution and scale, to transform how we understand, diagnose and treat disease

    Business Wire
  • cTAP Announces Novel Prognostic Score Developed for Duchenne Muscular Dystrophy Patients Offers Improved Prediction of Loss of Ambulation

    Business Wire
  • Alkermes Presents Detailed Positive Results From Vibrance-2 Phase 2 Study of Alixorexton in Adults With Narcolepsy Type 2 at SLEEP 2026

    Business Wire
  • Overture Life Launches Global ICSI.A Center of Excellence Program, Bringing the World’s First Automated ICSI into Clinical Use Across Five Leading Global Fertility Centers

    Business Wire
  • Anocca has Dosed First Patients with Precision TCR-T Cell Therapy Targeting Mutant KRAS in Pancreatic Cancer

    Business Wire
  • IMU Biosciences Selects Waters to Advance Breakthrough AI Immune Mapping Platform to Transform Early Diagnosis, Monitoring, and Precision Medicine

    Business Wire
  • Araris Biotech AG and Taiho Oncology Announce Dosing of First Patient in Phase 1 Trial of ARC-02, a Novel ADC for the Treatment of Non-Hodgkin Lymphoma

    Business Wire
  • Semble Secures £30M Series C Investment Led by Revaia to Expand Europe’s Connected Healthcare Platform

    Business Wire

City PM — European politics, business and analysis.

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Topics

  • Business
  • Markets
  • AI
  • Technology
  • Opinion
  • Energy

More

  • Politics
  • Economics
  • Fintech
  • Legal
  • Sport
  • Life

Company

  • About City PM
  • Editorial Policy
  • Corrections
  • Contact
  • Terms of Use
  • Privacy Policy
  • Cookie Policy
© 2026 City PM · Published by CityPM Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
About · Editorial Policy · Corrections · Contact · Privacy